#outpatients — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #outpatients, aggregated by home.social.
-
Don't think the staff working in NHS outpatients get enough praise. Accompanied someone to GP yesterday. They got a paper form with a barcode for a walk-in X-ray clinic. Turned up, one beep of scanner all those personal details already known. 2 mins in waiting area. X-ray of ankle? Put stopwatch on it, 4min 56s from start to finish. Well done all 👏
-
Don't think the staff working in NHS outpatients get enough praise. Accompanied someone to GP yesterday. They got a paper form with a barcode for a walk-in X-ray clinic. Turned up, one beep of scanner all those personal details already known. 2 mins in waiting area. X-ray of ankle? Put stopwatch on it, 4min 56s from start to finish. Well done all 👏
-
Don't think the staff working in NHS outpatients get enough praise. Accompanied someone to GP yesterday. They got a paper form with a barcode for a walk-in X-ray clinic. Turned up, one beep of scanner all those personal details already known. 2 mins in waiting area. X-ray of ankle? Put stopwatch on it, 4min 56s from start to finish. Well done all 👏
-
Don't think the staff working in NHS outpatients get enough praise. Accompanied someone to GP yesterday. They got a paper form with a barcode for a walk-in X-ray clinic. Turned up, one beep of scanner all those personal details already known. 2 mins in waiting area. X-ray of ankle? Put stopwatch on it, 4min 56s from start to finish. Well done all 👏
-
Don't think the staff working in NHS outpatients get enough praise. Accompanied someone to GP yesterday. They got a paper form with a barcode for a walk-in X-ray clinic. Turned up, one beep of scanner all those personal details already known. 2 mins in waiting area. X-ray of ankle? Put stopwatch on it, 4min 56s from start to finish. Well done all 👏
-
Oral #Nirmatrelvir – Ritonavir for #Covid19 in Higher-Risk #Outpatients, https://etidiohnew.blogspot.com/2026/04/oral-nirmatrelvir-ritonavir-for-covid19.html
-
Whole-Genome #Analysis of #Influenza #H1N1pdm09 Viruses Isolated from ILI #Outpatients in #Myanmar & CA #Oseltamivir-Resistant Strains Present from 2015 to 2019 https://pubmed.ncbi.nlm.nih.gov/39205274/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=10ykRO9og5pGdo51l9DEPEpOJ3DVFIn__QK2QPM3dci1C1dEYq&fc=None&ff=20240831103754&v=2.18.0.post9+e462414
3 viruses possessed the #H275Y substitution in #neuraminidase protein, appearing to be community-acquired without prior administration of neuraminidase inhibitors. These viruses exhibited highly reduced susceptibility to #oseltamivir and #peramivir.
-
Whole- #Genome #Analysis of #Influenza #H1N1pdm09 Viruses Isolated from #ILI #Outpatients in #Myanmar & Community-Acquired #Oseltamivir - #Resistant Strains Present from 2015 to 2019 https://www.mdpi.com/1999-4915/16/8/1300
1 virus intra-subtype reassortment, collected in the '15 season. 3 viruses possessed #H275Y substitution in NA protein, appearing to be CA without prior administration of neuraminidase #inhibitors. These viruses exhibited highly reduced susceptibility to #oseltamivir & #peramivir.
-
Higher-Dose #Fluvoxamine and Time to Sustained #Recovery in #Outpatients With #COVID19, JAMA: https://jamanetwork.com/journals/jama/fullarticle/2812204?guestAccessKey=54d3e80d-56e9-4898-af7f-16af89f61123&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=111723&adv=000003719403
-
Higher-Dose #Fluvoxamine and Time to Sustained #Recovery in #Outpatients With #COVID19, JAMA: https://jamanetwork.com/journals/jama/fullarticle/2812204?guestAccessKey=54d3e80d-56e9-4898-af7f-16af89f61123&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=111723&adv=000003719403
-
Higher-Dose #Fluvoxamine and Time to Sustained #Recovery in #Outpatients With #COVID19, JAMA: https://jamanetwork.com/journals/jama/fullarticle/2812204?guestAccessKey=54d3e80d-56e9-4898-af7f-16af89f61123&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=111723&adv=000003719403
-
Higher-Dose #Fluvoxamine and Time to Sustained #Recovery in #Outpatients With #COVID19, JAMA: https://jamanetwork.com/journals/jama/fullarticle/2812204?guestAccessKey=54d3e80d-56e9-4898-af7f-16af89f61123&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=111723&adv=000003719403
-
Higher-Dose #Fluvoxamine and Time to Sustained #Recovery in #Outpatients With #COVID19, JAMA: https://jamanetwork.com/journals/jama/fullarticle/2812204?guestAccessKey=54d3e80d-56e9-4898-af7f-16af89f61123&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=111723&adv=000003719403
-
A retrospective cohort study of prescribing #outcomes in #outpatients treated with #nirmatrelvir–Ritonavir for #COVID19 in an interdisciplinary community clinic https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0293302
-
[Articles] Real-world use of #nirmatrelvir–ritonavir in #outpatients with #COVID19 during the era of #omicron #variants including #BA4 and #BA5 in #Colorado, #USA: a retrospective cohort study https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext?rss=yes
-
McCarthy MW, Naggie S, Boulware DR, et al. Effect of #Fluvoxamine vs Placebo on Time to Sustained #Recovery in #Outpatients With Mild to Moderate #COVID19: A Randomized Clinical Trial. JAMA. Published online January 12, 2023. doi:10.1001/jama.2022.24100